Form 8-K - Current report:
SEC Accession No. 0001628280-25-051641
Filing Date
2025-11-12
Accepted
2025-11-12 16:35:42
Documents
12
Period of Report
2025-11-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20251106.htm   iXBRL 8-K 48011
  Complete submission text file 0001628280-25-051641.txt   168274

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20251106.xsd EX-101.SCH 1807
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20251106_lab.xml EX-101.LAB 22804
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20251106_pre.xml EX-101.PRE 13066
14 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20251106_htm.xml XML 2800
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 251473561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)